Laurie Toich, Assistant Editor

System improves commination between primary care providers and pharmacists.

Researchers assess the monetary value for improved health status.

Darapladib can block Lp-PLA2, which can lead to diabetes-related vision loss.

Top news of the day from across the healthcare landscape.

Accountable Care Organizations saved $456 per patient per year for Medicare beneficiaries with 3 or more conditions.

Novel therapy dissolves blood clots 4000 times faster than traditional thrombosis treatments.

Certain characteristics could potentially make patients more likely to need assistance with their medications.

Genetics could affect response to treatment for patients with Parkinson’s disease.

Pharmacy benefit managers may play a significant role in reducing medical costs.

Approximately 47.1% of physicians accepted a payment from drug industry companies.

Approximately 24 to 25% of patients with type 2 diabetes and heart failure died within 18 months.

Healthy T cells from a donor were able to recognize cancer cells that patients’ T cells were not able to.

RANK-inhibitor denosumab was able to stop cell growth and reduce cancer development in breast cancer samples with mutated-BRCA1.

The earlier statin therapy is administered, the greater the decrease of infection risk.

Top news of the day from across the healthcare landscape.

Insurers have taken interest in outcomes-based contracts for specialty drugs and non-specialty drugs.

Data from real-world use is important for patients and payers to understand how drugs work in uncontrolled environments.

Pediatric patients who underwent prolonged treatment with antibiotics showed a change in intestinal bacteria even after cessation of treatment.

Patients treated with statins who had high levels of LDL-C had an increased risk of cardiovascular events.

Top news of the day from across the healthcare landscape.

A combination approach that targets stromal and pancreatic cancer cells showed decreased cancer cell proliferation and invasion.

Patients with heart failure who have had 3 or more vaccines had a 55% decreased risk of developing dementia.

The certification of data could lead to widespread use of real-world evidence regarding the efficacy of drugs in clinical trials.

Fee-for-Service Medicare beneficiaries with heart failure accounted for 55.3% of readmissions.

Merck and Pfizer teamed up to create a new type 2 diabetes drug.

Females diagnosed with migraines had a 50% higher rate of cardiovascular events.

Addition of drug counteracted the tolerance of tuberculosis to another anti-tubercular drug.

Top news of the day from across the healthcare landscape.

Patients who signed up for Medicaid post-expansion had a better chance of getting an initial appointment.

Reading mammograms for longer periods of time did not reduce cancer detection, but increased overall performance.